NAUT vs. FEIM, MASS, QSI, QTRX, KEQU, OWLT, SEER, RPID, PRE, and INTT
Should you be buying Nautilus Biotechnology stock or one of its competitors? The main competitors of Nautilus Biotechnology include Frequency Electronics (FEIM), 908 Devices (MASS), Quantum-Si (QSI), Quanterix (QTRX), Kewaunee Scientific (KEQU), Owlet (OWLT), Seer (SEER), Rapid Micro Biosystems (RPID), Prenetics Global (PRE), and inTEST (INTT). These companies are all part of the "measuring and control equipment" industry.
Nautilus Biotechnology vs. Its Competitors
Frequency Electronics (NASDAQ:FEIM) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.
Frequency Electronics has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.
58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are owned by institutional investors. 26.1% of Frequency Electronics shares are owned by insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Nautilus Biotechnology has a consensus price target of $2.13, suggesting a potential upside of 203.14%. Given Nautilus Biotechnology's stronger consensus rating and higher probable upside, analysts plainly believe Nautilus Biotechnology is more favorable than Frequency Electronics.
Frequency Electronics has a net margin of 34.09% compared to Nautilus Biotechnology's net margin of 0.00%. Frequency Electronics' return on equity of 53.83% beat Nautilus Biotechnology's return on equity.
In the previous week, Frequency Electronics had 1 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 1 mentions for Frequency Electronics and 0 mentions for Nautilus Biotechnology. Frequency Electronics' average media sentiment score of 0.65 beat Nautilus Biotechnology's score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the media.
Frequency Electronics has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, Nautilus Biotechnology has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500.
Summary
Frequency Electronics beats Nautilus Biotechnology on 10 of the 14 factors compared between the two stocks.
Get Nautilus Biotechnology News Delivered to You Automatically
Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NAUT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nautilus Biotechnology Competitors List
Related Companies and Tools
This page (NASDAQ:NAUT) was last updated on 8/24/2025 by MarketBeat.com Staff
MarketBeat All Access